4/A
Changes in Ownership
Gain Therapeutics, Inc. Filed Acc 0001209191-22-025180
Chief Executive Officer bought 4,922 shares at $7.87 ($38,716)
From the SEC's structured data for this filing
Gain Therapeutics, Inc. Filed Acc 0001209191-22-025180
Chief Executive Officer bought 4,922 shares at $7.87 ($38,716)
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…